Neoadjuvant Low-dose Immunotherapy in Locally Advanced MMR-deficient Colorectal Cancer

Clinical trial NCT07523763 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07523763
Sponsor: Blokhin's Russian Cancer Research Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer (MSI-H)Colorectal Cancer (CRC)

Start date: 2024-03-22
Primary completion: 2025-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.